# FDA 483 - Andrew M. Schneider, MD - November 07, 2025

Source: https://www.keypedia.com/records/483/andrew-m-schneider-md/6cd67e4b-e646-4582-85d2-bc213d5eea38

> FDA 483 for Andrew M. Schneider, MD on November 07, 2025. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Andrew M. Schneider, MD
- Inspection Date: 2025-11-07
- Product Type: other
- Office Name: Florida District Office
- Summary: An FDA inspection of Andrew M. Schneider, MD, a clinical investigator in Tamarac, FL, revealed one observation related to the conduct of a clinical investigation. The firm failed to conduct an investigation in accordance with the signed statement of investigator and investigational plan. Specifically, required documentation was not submitted for a randomized subject per protocol and inclusion criteria.

## Related Officers

- [investigator](https://www.keypedia.com/people/ana-p-barido/4af1fa64-245e-4470-bd4b-975681d10a77)
- [investigator](https://www.keypedia.com/people/emily-a-baldwin/92d70174-7029-44f4-af30-e3230d4e9507)

Company: https://www.keypedia.com/companies/andrew-m-schneider-md/ad126efa-450a-4547-979d-35749aa0f1a6

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9